ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
33 announcements with these filters
India Glycols Limited announced that its subsidiary, IGL Spirits Limited, approved share allotment under a Scheme of Arrangement and appointed new key managerial personnel.
India Glycols Ltd announced that four senior management personnel ceased their roles following the effective date of a previously disclosed Scheme of Arrangement.
India Glycols Limited has completed its demerger into three separate entities effective September 1, 2026. The scheme, sanctioned by the NCLT, is now operational.
India Glycols' subsidiary, Ennature Bio Pharma, announced the appointment of new Directors and a Managing Director. These appointments are part of ongoing corporate updates.
India Glycols Ltd received the certified NCLT order approving the Scheme of Arrangement, which involves the demerger of its Biopharma, Spirits, and Biofuel undertakings.
India Glycols held its 42nd Annual General Meeting on August 19, 2026. Shareholders approved all resolutions, including the final dividend payout.
India Glycols Limited clarified that there is no undisclosed information causing the recent increase in trading volume. The company attributes the surge to market forces.
India Glycols posted a record Q1 with 19% net revenue growth and 32% PAT growth, driven by its Bio-Pharma segment. Management is aggressively pivoting toward a premium-led consumer model through restructuring and new liquor brand partnerships.
India Glycols reported strong Q1FY27 results with 19% Gross Revenue growth and 32% PAT growth, driven by a diversified portfolio and a demerger strategy into three focused platforms.
India Glycols is sending a reminder to physical security holders to update their PAN, KYC, and nomination details as per SEBI regulations. This is a routine compliance communication.
India Glycols Ltd re-designated Ms. Pragya Bhartia Barwale from Whole Time Director and KMP to Non-Executive Non-Independent Director, effective August 12, 2026.
India Glycols Ltd reported revenue from operations of ₹2,988 Cr (+19.4% YoY) and net profit of ₹96.8 Cr (+32.2% YoY) for Q1 FY27.
India Glycols has scheduled a board meeting for August 12, 2026, to approve the company's unaudited financial results for the first quarter ended June 30, 2026.
Shri Akshay Bansal, a Senior Managerial Personnel (SMP) at India Glycols Limited, has been transferred to its subsidiary, Ennature Bio Pharma Limited, as an Executive Director.
India Glycols Limited has shared the web-link for accessing the 42nd AGM Notice and Annual Report for FY 2025-26 with shareholders having unregistered email addresses.
India Glycols Ltd submitted its Business Responsibility and Sustainability Report (BRSR) for FY 2025-26. The report forms part of the company's annual report.
India Glycols Limited has issued a notice for its Annual General Meeting on August 19, 2026. The meeting will cover financial statements and dividend confirmation.
India Glycols Limited has scheduled its 42nd Annual General Meeting for August 19, 2026, via video conferencing. Relevant notices and annual reports will be circulated to shareholders.
NCLT Allahabad Bench has sanctioned India Glycols Limited's demerger scheme. The Bio Pharma, Spirits, and Biofuel undertakings will be transferred to resulting companies EBL and ISL.
India Glycols Ltd's demerger scheme received NCLT approval. The tribunal reserved its final order, pending resolution of tax-related matters.
India Glycols' subsidiary IGL Spirits appointed Manoj Kumar Rai as COO. His 27-year experience in beverages and consumer goods is key for the role.
India Glycols reported a strong FY26 with net revenue of ₹4,211cr (up 11.8%) and PAT of ₹293cr (up 26.8%). Strategy focuses on premiumization in spirits and expanding bio-based chemicals.
India Glycols filed for mediation to recover a ₹79.76 Crore insurance claim against New India Assurance. The claim relates to material damage and business losses.
India Glycols' NCLT hearing for its Scheme of Arrangement was deferred due to paucity of time. A new hearing date is yet to be notified.
India Glycols Limited filed its Annual Secretarial Compliance Report for FY 2025-26. The report by Mukesh Agarwal & Co. confirms adherence to SEBI listing and disclosure regulations.
India Glycols delivered solid FY26 performance led by portable spirits and biofuels, successfully deleveraging the balance sheet through promoter equity infusion and internal accruals while shifting toward a premium-led liquor portfolio.
India Glycols delivered strong FY26 performance with 11.8% Net Revenue growth and 26.8% PAT growth. Management is executing a three-way demerger into Chemicals, Spirits/Bio-Fuel, and Bio-Pharma entities.
India Glycols approved re-appointing S.S. Kothari Mehta & Co. and R.J. Goel & Co. as auditors. The move ensures regulatory compliance for FY 2026-27.
India Glycols Ltd reported revenue from operations of ₹2,360 Cr (+7.8% YoY) and net profit of ₹86.9 Cr (+35.8% YoY) for Q4 FY26.
India Glycols reported a standalone total income of ₹9,869.71 Crore for FY26. The board also approved a demerger of its spirits and biofuel undertakings.